Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Ulpax

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

109 API Suppliers, 38 USDMF, 23 CEP/COS, 17 JDMF, 17 EU WC, 17 KDMF, 18 NDC API, 52 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

834 FDF Dossiers, 68 FDA Orange Book, 532 Europe, 25 Canada, 59 Australia, 40 South Africa, 110 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 30MG, CAPSULE, DELAYED REL PELLETS;ORAL - 15MG, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 8 Evonik, 7 Rochem International Inc, 23 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 2 Clariant, 14 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 47 Thickeners and Stabilizers, 39 Taste Masking, 37 Solubilizers, 37 Controlled & Modified Release, 35 Direct Compression, 28 Film Formers & Plasticizers, 27 Parenteral, 27 Granulation, 25 Topical, 23 Lubricants & Glidants, 23 Disintegrants & Superdisintegrants, 22 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 12 Emulsifying Agents, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 9 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

221 News #PharmaBuzz

221 News #PharmaBuzz

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 279 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

20 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 18 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Metrochem API Private Limited	India	METROCHEM API PRIVATE LIMITED Hyderabad IN	CEP 2021-009 - Rev 03	Lansoprazole	2024-12-02	Valid	Chemical		2219
29/11/2025	CHEMO IBERICA SA	Spain	CHEMO IBERICA S.A. Madrid ES	R1-CEP 2008-016 - Rev 00	Lansoprazole	2014-07-18	Withdrawn by Holder	Chemical	2022-01-14	2219

Ulpax

Ulpax

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

109 API Suppliers

38 USDMF

23 CEP/COS

17 JDMF

17 EU WC

17 KDMF

18 NDC API

52 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

834 FDF Dossiers

68 FDA Orange Book

532 Europe

25 Canada

59 Australia

40 South Africa

110 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 30MG

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

8 Evonik

7 Rochem International Inc

23 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

2 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

8 Kirsch Pharma

4 ACG Worldwide

10 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

26 BASF

1 Bioplus Life Sciences

3 CD Formulation

2 Clariant

14 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

3 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

12 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

40 Roquette

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons